O43557 (TNF14_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 132.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Tumor necrosis factor ligand superfamily member 14 Alternative name(s): Herpes virus entry mediator ligand Short name=HVEM-L Short name=Herpesvirus entry mediator ligand CD_antigen=CD258 Cleaved into the following 2 chains: | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 240 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus. |
| Subunit structure | Homotrimer. |
| Subcellular location | Tumor necrosis factor ligand superfamily member 14, membrane form: Cell membrane; Single-pass type II membrane protein. Tumor necrosis factor ligand superfamily member 14, soluble form: Secreted. |
| Tissue specificity | Predominantly expressed in the spleen but also found in the brain. Weakly expressed in peripheral lymphoid tissues and in heart, placenta, liver, lung, appendix, and kidney, and no expression seen in fetal tissues, endocrine glands, or nonhematopoietic tumor lines. |
| Induction | Up-regulated after T-cell activation. |
| Post-translational modification | N-glycosylated. Ref.9 The soluble form of isoform 1 derives from the membrane form by proteolytic processing. |
| Sequence similarities | Belongs to the tumor necrosis factor family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| TNFRSF14 | Q92956 | 2 | EBI-524131,EBI-1056653 | |
| TNFRSF6B | O95407 | 2 | EBI-524131,EBI-524171 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O43557-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O43557-2) Also known as: LIGHT delta-TM; The sequence of this isoform differs from the canonical sequence as follows: 38-73: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 240 | 240 | Tumor necrosis factor ligand superfamily member 14, membrane form | PRO_0000034532 | |||||||||||||||||||||||||||||||
| Chain | ?83 – 240 | 158 | Tumor necrosis factor ligand superfamily member 14, soluble form | PRO_0000034533 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Topological domain | 1 – 37 | 37 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 38 – 58 | 21 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 59 – 240 | 182 | Extracellular Potential | ||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||
| Site | 82 – 83 | 2 | Cleavage Potential | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Glycosylation | 102 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||||||||||||||||||||||||||||
| Disulfide bond | 154 ↔ 187 | Ref.9 | |||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 38 – 73 | 36 | Missing in isoform 2. | VSP_006452 | |||||||||||||||||||||||||||||||
| Natural variant | 32 | 1 | S → L. Corresponds to variant rs2291667 [ dbSNP | Ensembl ]. | VAR_027677 | |||||||||||||||||||||||||||||||
| Natural variant | 120 | 1 | L → V. Corresponds to variant rs17851606 [ dbSNP | Ensembl ]. | VAR_027678 | |||||||||||||||||||||||||||||||
| Natural variant | 214 | 1 | K → E. Ref.1 Ref.3 Ref.4 Ref.6 Ref.8 Corresponds to variant rs344560 [ dbSNP | Ensembl ]. | VAR_027679 | |||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 95 – 102 | 8 | |||||||||||||||||||||||||||||||||
| Helix | 106 – 108 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 113 – 118 | 6 | |||||||||||||||||||||||||||||||||
| Beta strand | 122 – 129 | 8 | |||||||||||||||||||||||||||||||||
| Beta strand | 132 – 137 | 6 | |||||||||||||||||||||||||||||||||
| Beta strand | 139 – 152 | 14 | |||||||||||||||||||||||||||||||||
| Beta strand | 162 – 169 | 8 | |||||||||||||||||||||||||||||||||
| Beta strand | 176 – 184 | 9 | |||||||||||||||||||||||||||||||||
| Helix | 186 – 189 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 197 – 209 | 13 | |||||||||||||||||||||||||||||||||
| Beta strand | 214 – 221 | 8 | |||||||||||||||||||||||||||||||||
| Helix | 229 – 232 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 234 – 239 | 6 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator." Mauri D.N., Ebner R., Montgomery R.I., Kochel K.D., Cheung T.C., Yu G.-L., Ruben S., Murphy M., Eisenberg R.J., Cohen G.H., Spear P.G., Ware C.F. Immunity 8:21-30(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLU-214. |
| [2] | "Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth." Harrop J.A., McDonnell P.C., Brigham-Burke M., Lyn S.D., Minton J., Tan K.B., Dede K., Spampanato J., Silverman C., Hensley P., DiPrinzio R., Emery J.G., Deen K., Eichman C., Chabot-Fletcher M., Truneh A., Young P.R. J. Biol. Chem. 273:27548-27556(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION. Tissue: Liver. |
| [3] | "Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis." Granger S.W., Butrovich K.D., Houshmand P., Edwards W.R., Ware C.F. J. Immunol. 167:5122-5128(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEOLYTIC PROCESSING, VARIANT GLU-214. |
| [4] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT GLU-214. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Spleen. |
| [6] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT GLU-214. |
| [7] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT GLU-214. |
| [9] | "Crystal structure of LIGHT." New York structural genomics research consortium (NYSGRC) Submitted (MAY-2012) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 83-240, GLYCOSYLATION AT ASN-102, DISULFIDE BOND. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF036581 mRNA. Translation: AAC39563.1. AF064090 mRNA. Translation: AAC25169.1. AY028261 mRNA. Translation: AAK26160.1. AY358812 mRNA. Translation: AAQ89171.1. AK292037 mRNA. Translation: BAF84726.1. CR541854 mRNA. Translation: CAG46652.1. CR541871 mRNA. Translation: CAG46669.1. AC008760 Genomic DNA. No translation available. CH471139 Genomic DNA. Translation: EAW69072.1. | ||||||||||||||||||
| IPI | IPI00221341. IPI00307531. | ||||||||||||||||||
| RefSeq | NP_003798.2. NM_003807.3. NP_742011.2. NM_172014.2. | ||||||||||||||||||
| UniGene | Hs.129708. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | O43557. | ||||||||||||||||||
| SMR | O43557. Positions 93-240. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-3016N. | ||||||||||||||||||
| IntAct | O43557. 3 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000245912. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | O43557. | ||||||||||||||||||
| PRIDE | O43557. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 8740. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000245912; ENSP00000245912; ENSG00000125735. ENST00000326176; ENSP00000326940; ENSG00000125735. ENST00000599359; ENSP00000469049; ENSG00000125735. | ||||||||||||||||||
| GeneID | 8740. | ||||||||||||||||||
| KEGG | hsa:8740. | ||||||||||||||||||
| UCSC | uc002mfj.2. human. uc002mfk.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 8740. | ||||||||||||||||||
| GeneCards | GC19M006663. | ||||||||||||||||||
| HGNC | HGNC:11930. TNFSF14. | ||||||||||||||||||
| HPA | HPA012700. | ||||||||||||||||||
| MIM | 604520. gene. | ||||||||||||||||||
| neXtProt | NX_O43557. | ||||||||||||||||||
| PharmGKB | PA36622. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG40950. | ||||||||||||||||||
| HOVERGEN | HBG061471. | ||||||||||||||||||
| InParanoid | O43557. | ||||||||||||||||||
| KO | K05477. | ||||||||||||||||||
| OMA | ITHGLYK. | ||||||||||||||||||
| OrthoDB | EOG4MKNHT. | ||||||||||||||||||
| PhylomeDB | O43557. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| Bgee | O43557. | ||||||||||||||||||
| CleanEx | HS_TNFSF14. | ||||||||||||||||||
| Genevestigator | O43557. | ||||||||||||||||||
| GermOnline | ENSG00000125735. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 2.60.120.40. 1 hit. | ||||||||||||||||||
| InterPro | IPR006052. TNF. IPR006053. TNF_a/b/c. IPR008983. Tumour_necrosis_fac-like_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF00229. TNF. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR01234. TNECROSISFCT. | ||||||||||||||||||
| SMART | SM00207. TNF. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF49842. TNF_like. 1 hit. | ||||||||||||||||||
| PROSITE | PS00251. TNF_1. False negative. PS50049. TNF_2. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| GenomeRNAi | 8740. | ||||||||||||||||||
| NextBio | 32787. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | TNF14_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O43557 Secondary accession number(s): A8K7M2 Q96LD2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
